The healthcare industry is rapidly adopting 3D printing solutions due to benefits such as unmatched flexibility of design and low-cost production of prosthetics, implants, medical devices, and anatomical models. With technology progression and regulatory issues becoming clearer, this market will witness quantum change in terms of healthcare service possibilities.
Killing senescent or zombie cells that have stopped dividing could slow or prevent many diseases linked to ageing such as lung infections, heart disease, osteoarthritis and even diabetes. Anthony King reports
Political instability, competition and digitisation are having a dramatic impact on the chemicals sector, reports Kiran Pudi, senior director at Simon Kucher
A new take on controlled cationic polymerisation, a toughened glass inspired by nacre, Photosynthetic syngas, Mg3Bi2 thermoelectrics
Pharma major AstraZeneca, headquartered in Cambridge, UK, has amended its collaboration agreement with US pharmaceutical company Ironwood Pharmaceuticals. AstraZeneca now has sole responsibility for the R&D, manufacture and commercialisation of the irritable bowel syndrome (IBS) treatment Linzess in mainland China, Hong Kong and Macau.
Stroke is the fifth leading cause of death in the US and the leading cause of adult disability, yet no new drug treatment has been approved in 20 years. But now a range of therapies are entering human trials, Jasmin Fox-Skelly reports.
People suffering from debilitating and often discounted chronic fatigue syndrome – also known as ME – may soon have something they’ve been seeking for decades: scientific proof of their ailment. Maria Burke reports
The recent withdrawal of valsartan-containing antihypertensives was caused by low-level genotoxic impurities in the bulk API used to make them. The source was traced back to a Chinese manufacturer, and the contamination identified as the carcinogen N-nitrosodimethylamine (NDMA). Further investigations showed that other manufacturers had also supplied contaminated API, and additionally, a related impurity, N-nitrosodiethylamine (NDEA), was also found in other valsartan products.
Industry 4.0. The industrial internet of things. Digitalisation. Smart manufacturing. The fourth industrial revolution. There are dozens of different names for the uptake in connected technologies and the convergence of IT and OT systems taking place in industry at the moment. One thing most people do agree on, however, is that it’s tech-driven. But should this really be the case?
Every so often someone demonstrates viability of an idea that is elegant because of its simplicity. Perrin’s group at the University of British Columbia has impressed me this way twice; firstly with their 18F capture-agents for positron emission tomography, and the second just appeared (Angew. Chem, doi: 10.1002/anie.201906514).